Small Molecules
28 April 2016
Alkermes Announces Plan to Initiate Second Clinical Trial of ALKS 7119 Based on Preliminary Phase 1 Results27 April 2016
BERG Initiates Phase II Combination Trial Of BPM 31510 And Gemcitabine In Patients With Pancreatic Cancer26 April 2016
Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT70123 April 2016
Kineta Presents Promising New Data on Novel Lassa Fever Antiviral and Broad Spectrum Innate Immune Antivirals23 April 2016
FDA Accepts Lundbeck Resubmission of New Drug Application for Carnexiv™ (carbamazepine)21 April 2016
Basilea reports presentation of data on clinical oncology programs BAL101553 and BAL3833 at AACR meeting21 April 2016
MedDay Reports Full Data from Pivotal Phase IIb/III MS-SPI / MS-ON Studies with MD1003 in Multiple Sclerosis at AAN20 April 2016
Novartis drug Afinitor® significantly reduces seizures in Phase III study of patients with tuberous sclerosis complex20 April 2016
X4 Pharmaceuticals Announces Data Presentation for Lead Candidate X4P-001 at AACR Annual MeetingNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports